Latest filing published 05 May 2025 for Vertex Pharmaceuticals INC / MA. Read the official filing
No signal scores available.
This profile gathers the share dealings of Jennifer Schneider in Vertex Pharmaceuticals INC / MA. Over a trading history stretching from 15 May 2024 to 1 May 2025, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 5 May 2025: a share grant, in Vertex Pharmaceuticals INC / MA. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations